Clinical Trial to Assess the Safety and Tolerability of Anti‐<scp>IL</scp> 23 Monoclonal Antibody Guselkumab in Patients With Alcohol‐Associated Liver DiseaseLuis Antonio Díaz, Rohit Loomba, Shravan Dave et al.|Alimentary Pharmacology & Therapeutics|2025Cited by 4